[144] HealthEquity, Inc SEC Filing

Rhea-AI Filing Summary

Sunrun Inc. (RUN) has filed a Form 144 indicating a proposed sale of restricted securities.

• Securities to be sold: 988 common shares
• Aggregate market value: $10,670
• Approximate sale date: 07/07/2025
• Broker: Charles Schwab & Co., Inc.
• Exchange: NASDAQ
• Total shares outstanding: 228,486,470
• Recent prior sales by same seller: 2,729 shares on 04/07/2025 for gross proceeds of $18,379

The planned sale represents roughly 0.0004% of Sunrun’s outstanding shares, suggesting minimal dilution or market impact. The shares were acquired via an RSU lapse (equity compensation) on 07/07/2025. Form 144 also affirms that the filer possesses no undisclosed material adverse information about Sunrun.

Insights

Securities Analyst

TL;DR: Tiny Form 144 sale (988 shares) is immaterial to RUN; neutral impact.

The filing discloses a proposed sale worth only $10.7k versus Sunrun’s 228.5 million shares outstanding. Even coupled with the earlier 2,729-share sale, the volumes are immaterial and unlikely to affect liquidity, float, or sentiment. No relationship to the issuer (e.g., insider status) is specified, reducing interpretative weight. Overall, the notice is routine administrative disclosure with negligible investment significance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1794	183275.04	86475351	07/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2025	Restricted Stock Units	Issuer			1794	07/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Sunrun (RUN) shares are proposed to be sold under this Form 144?

A total of 988 common shares are listed for sale.

What is the aggregate market value of the shares to be sold?

The filing lists an aggregate market value of $10,670.

When is the approximate sale date for the shares?

The shares are expected to be sold on 07/07/2025.

On which exchange will the Sunrun shares be sold?

The shares are slated for sale on the NASDAQ.

How many shares has the same seller disposed of in the last three months?

The seller previously sold 2,729 shares on 04/07/2025 for gross proceeds of $18,379.

What is the total number of Sunrun shares outstanding?

The filing cites 228,486,470 shares outstanding.